Search Results - "Desai, Neil P"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status by Desai, Neil P, Trieu, Vuong, Hwang, Larn Yuan, Wu, Rujin, Soon-Shiong, Patrick, Gradishar, William J

    Published in Anti-cancer drugs (01-10-2008)
    “…Nanoparticle albumin-bound (nab)-paclitaxel (Abraxane) is an albumin-bound 130-nm particle form of paclitaxel that demonstrated higher efficacy and was well…”
    Get full text
    Journal Article
  2. 2

    nab -Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors by Wagner, Andrew J, Ravi, Vinod, Riedel, Richard F, Ganjoo, Kristen, Van Tine, Brian A, Chugh, Rashmi, Cranmer, Lee, Gordon, Erlinda M, Hornick, Jason L, Du, Heng, Grigorian, Berta, Schmid, Anita N, Hou, Shihe, Harris, Katherine, Kwiatkowski, David J, Desai, Neil P, Dickson, Mark A

    Published in Journal of clinical oncology (20-11-2021)
    “…Malignant perivascular epithelioid cell tumor (PEComa) is a rare aggressive sarcoma, with no approved treatment. To our knowledge, this phase II, single-arm,…”
    Get full text
    Journal Article
  3. 3

    Endothelial Cell-Selective Materials for Tissue Engineering in the Vascular Graft Via a New Receptor by Hubbell, Jeffrey A, Massia, Stephen P, Desai, Neil P, Drumheller, Paul D

    Published in Bio/technology (New York, N.Y. 1983) (01-06-1991)
    “…We have found a novel adhesion receptor on the human endothelial cell for the peptide sequence Arg-Glu-Asp-Val (REDV), which is present in the III-CS domain of…”
    Get full text
    Journal Article
  4. 4

    Abstract B08: Improved tumor penetration, antitumor activity, and survival of ABI-009 (nab-sirolimus) versus oral rapamycin and everolimus and investigation of mTOR pathway inhibition by Schmid, Anita N., Hou, Shawn, Grigorian, Berta, Desai, Neil P.

    Published in Molecular cancer research (01-10-2020)
    “…Background: mTOR pathway is a key regulator of cell survival and proliferation and has been implicated in various indications, including oncology, hematology,…”
    Get full text
    Journal Article
  5. 5

    Abstract P138: nab -Sirolimus improves mTOR pathway suppression and antitumor activity versus oral mTOR inhibitors in PTEN null bladder cancer (UMUC3) and TSC2 null liver cancer (SNU398) xenografts by Hou, Shihe, Du, Heng, Schmid, Anita N., Kwiatkowski, David J., Desai, Neil P.

    Published in Molecular cancer therapeutics (01-12-2021)
    “…Background: TSC1, TSC2, and PTEN genes are tumor suppressors in the mTOR pathway and can be inactivated or deleted across many cancers (Kwiatkowski, Clin…”
    Get full text
    Journal Article
  6. 6

    Surface physical interpenetrating networks of poly(ethylene terephthalate) and poly(ethylene oxide) with biomedical applications by Desai, Neil P, Hubbell, Jeffrey A

    Published in Macromolecules (01-01-1992)
    “…Poly(ethylene terephthalate) (PET) films were modified by diffusing poly(ethylene oxide) (PEO) into the surface of the PET, which was swollen in a mutual…”
    Get full text
    Journal Article
  7. 7

    Molecular mass distribution of sodium alginate by high-performance size-exclusion chromatography by Ci, Sherry X, Huynh, Tanya H, Louie, Leslie W, Yang, Andrew, Beals, Bridget J, Ron, Nilesh, Tsang, Wen-Ghih, Soon-Shiong, Patrick, Desai, Neil P

    Published in Journal of Chromatography A (24-12-1999)
    “…A sensitive high-performance size-exclusion chromatography (HPSEC) method with simple UV detection was developed for the molecular mass analysis of sodium…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Biological responses to polyethylene oxide modified polyethylene terephthalate surfaces by Desai, N P, Hubbell, J A

    Published in Journal of biomedical materials research (01-07-1991)
    “…Polyethylene oxide (PEO) of molecular weights 5,000, 10,000, 18,500, and 100,000 g/mol was covalently grafted to surfaces of otherwise cell adhesive…”
    Get more information
    Journal Article
  10. 10

    Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials by Desai, N P, Hubbell, J A

    Published in Biomaterials (01-03-1991)
    “…A simple solution technique was used to incorporate polyethylene oxide (PEO, of 5000, 10,000, 18,500, and 100,000 g/mol) and other water-soluble polymers such…”
    Get more information
    Journal Article
  11. 11

    Surface-immobilized polyethylene oxide for bacterial repellence by Desai, N P, Hossainy, S F, Hubbell, J A

    Published in Biomaterials (1992)
    “…Polyethylene terephthalate films were surface-modified with polyethylene oxide (18,500 g/mol) using a solution technique described previously. These films were…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Tissue response to intraperitoneal implants of polyethylene oxide-modified polyethylene terephthalate by Desai, N P, Hubbell, J A

    Published in Biomaterials (1992)
    “…Polyethylene terephthalate films surface modified with polyethylene oxide of mol wt 18,500 g/mol (18.5 k) by a previously described technique, were implanted…”
    Get more information
    Journal Article
  14. 14
  15. 15

    The short-term blood biocompatibility of poly(hydroxyethyl methacrylate-co-methyl methacrylate) in an in vitro flow system measured by digital videomicroscopy by Desai, N P, Hubbell, J A

    “…An in vitro flow system for short-term blood biocompatibility testing of solution-castable polymeric biomaterials was developed. This system was relatively…”
    Get more information
    Journal Article